These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 17276500)
1. Regulation of the metastasis suppressor gene MKK4 in ovarian cancer. Spillman MA; Lacy J; Murphy SK; Whitaker RS; Grace L; Teaberry V; Marks JR; Berchuck A Gynecol Oncol; 2007 May; 105(2):312-20. PubMed ID: 17276500 [TBL] [Abstract][Full Text] [Related]
2. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation. Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529 [TBL] [Abstract][Full Text] [Related]
3. Loss of MKK4 expression in ovarian cancer: a potential role for the epithelial to mesenchymal transition. Yeasmin S; Nakayama K; Rahman MT; Rahman M; Ishikawa M; Katagiri A; Iida K; Nakayama N; Miyazaki K Int J Cancer; 2011 Jan; 128(1):94-104. PubMed ID: 20309881 [TBL] [Abstract][Full Text] [Related]
4. Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma. Yamada SD; Hickson JA; Hrobowski Y; Vander Griend DJ; Benson D; Montag A; Karrison T; Huo D; Rutgers J; Adams S; Rinker-Schaeffer CW Cancer Res; 2002 Nov; 62(22):6717-23. PubMed ID: 12438272 [TBL] [Abstract][Full Text] [Related]
5. Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers. Kim HL; Vander Griend DJ; Yang X; Benson DA; Dubauskas Z; Yoshida BA; Chekmareva MA; Ichikawa Y; Sokoloff MH; Zhan P; Karrison T; Lin A; Stadler WM; Ichikawa T; Rubin MA; Rinker-Schaeffer CW Cancer Res; 2001 Apr; 61(7):2833-7. PubMed ID: 11306453 [TBL] [Abstract][Full Text] [Related]
6. The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma. Hickson JA; Huo D; Vander Griend DJ; Lin A; Rinker-Schaeffer CW; Yamada SD Cancer Res; 2006 Feb; 66(4):2264-70. PubMed ID: 16489030 [TBL] [Abstract][Full Text] [Related]
7. NDN is an imprinted tumor suppressor gene that is downregulated in ovarian cancers through genetic and epigenetic mechanisms. Yang H; Das P; Yu Y; Mao W; Wang Y; Baggerly K; Wang Y; Marquez RT; Bedi A; Liu J; Fishman D; Lu Z; Bast RC Oncotarget; 2016 Jan; 7(3):3018-32. PubMed ID: 26689988 [TBL] [Abstract][Full Text] [Related]
8. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic and genetic alterations of p33ING1b in ovarian cancer. Shen DH; Chan KY; Khoo US; Ngan HY; Xue WC; Chiu PM; Ip P; Cheung AN Carcinogenesis; 2005 Apr; 26(4):855-63. PubMed ID: 15677627 [TBL] [Abstract][Full Text] [Related]
10. MKK4 acts as a potential tumor suppressor in ovarian cancer. Yeasmin S; Nakayama K; Rahman MT; Rahman M; Ishikawa M; Katagiri A; Iida K; Nakayama N; Miyazaki K Tumour Biol; 2011 Aug; 32(4):661-70. PubMed ID: 21487811 [TBL] [Abstract][Full Text] [Related]
11. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas. Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387 [TBL] [Abstract][Full Text] [Related]
12. c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip.1 ovarian cancer metastasis involves growth arrest and p21 up-regulation. Lotan T; Hickson J; Souris J; Huo D; Taylor J; Li T; Otto K; Yamada SD; Macleod K; Rinker-Schaeffer CW Cancer Res; 2008 Apr; 68(7):2166-75. PubMed ID: 18381422 [TBL] [Abstract][Full Text] [Related]
13. Hypermethylation, but not LOH, is associated with the low expression of MT1G and CRABP1 in papillary thyroid carcinoma. Huang Y; de la Chapelle A; Pellegata NS Int J Cancer; 2003 May; 104(6):735-44. PubMed ID: 12640681 [TBL] [Abstract][Full Text] [Related]
14. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines. Kim YI; Shin MK; Lee JW; Chung JH; Lee MH Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457 [TBL] [Abstract][Full Text] [Related]
15. Mitogen-activated protein kinase kinase 4/c-Jun NH2-terminal kinase kinase 1 protein expression is subject to translational regulation in prostate cancer cell lines. Robinson VL; Shalhav O; Otto K; Kawai T; Gorospe M; Rinker-Schaeffer CW Mol Cancer Res; 2008 Mar; 6(3):501-8. PubMed ID: 18337456 [TBL] [Abstract][Full Text] [Related]
16. Downregulation of metallothionein 1F, a putative oncosuppressor, by loss of heterozygosity in colon cancer tissue. Yan DW; Fan JW; Yu ZH; Li MX; Wen YG; Li DW; Zhou CZ; Wang XL; Wang Q; Tang HM; Peng ZH Biochim Biophys Acta; 2012 Jun; 1822(6):918-26. PubMed ID: 22426038 [TBL] [Abstract][Full Text] [Related]
17. Genetic and epigenetic analysis of the TIMP-3 gene in ovarian cancer. Liu MC; Choong DY; Hooi CS; Williams LH; Campbell IG Cancer Lett; 2007 Mar; 247(1):91-7. PubMed ID: 16644110 [TBL] [Abstract][Full Text] [Related]
18. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma]. Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553 [TBL] [Abstract][Full Text] [Related]
19. STAT3 acetylation-induced promoter methylation is associated with downregulation of the ARHI tumor-suppressor gene in ovarian cancer. Li J; Cui G; Sun L; Wang SJ; Li YL; Meng YG; Guan Z; Fan WS; Li LA; Yang YZ; You YQ; Fu XY; Yan ZF; Huang K Oncol Rep; 2013 Jul; 30(1):165-70. PubMed ID: 23604529 [TBL] [Abstract][Full Text] [Related]
20. [Hypermethylation of fragile histidine triad gene and 3p14 allelic deletion in ovarian carcinomas]. Hong FZ; Wang B; Li HM; Liew CT Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):257-61. PubMed ID: 16181544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]